About Us

About ResMed

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

126 million+ lives changed in the last 12 months
15 million+ 100% cloud-connectable devices on the market
3.5 million+ CPAP users have signed up for myAir
Our strategy is to change the lives of 250 million people in 2025
 
 
 

Read more about ResMed at the following link